Rockville Centre, New York, Oct. 24, 2017 -- Head lice infamously cause stress, disgust and embarrassment for millions of parents whose kids get infested each year. Parents in Rockville Centre on Long Island no longer have to worry about treating the bugs themselves thanks to the opening of a new clinic, Lice Clinics of America. Lice Clinics of America – Rockville Centre (http://www.liceclinicslongisland.com) provides screening, diagnosis and treatment options for people infested with head lice. The clinic is staffed by certified operators of the AirAllé device, an FDA-cleared medical device that kills head lice and lice eggs using just heated air.
Treatment using the AirAllé takes about an hour and has proven more than 99 percent effective in more than 350,000 treatments. Manager Jesse Curatolo is excited about the opportunity to help parents and children through a stressful time. “I joined the Lice Clinics of America Long Island team because I see it as an opportunity to provide a service that families urgently need when they have lice,” Jesse said. “It feels great to be able to offer an immediate, affordable and guaranteed effective solution to people who are desperate for help.”
Lice Clinics of America – Long Island is located at 566 Merrick Road in Rockville Centre. The clinic is open seven days per week by appointment. The AirAllé treatment comes with a 30-day guarantee when all family members are treated or screened for head lice. The new clinic is one of more than 300 clinics in the Lice Clinics of America network. With clinics in more than 33 countries, Lice Clinics of America (www.LiceClinicsOfAmerica.com) is the largest network of professional head-lice-treatment centers in the world. Lice Clinics of America and AirAllé (www.airalle.com) are brands owned by Larada Sciences, Inc.
|
|||
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/badc550c-cc0c-409a-a2ed-0f030b807485
Jesse Curatolo Lice Clinics of Long Island 516-336-4099 [email protected]


Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
China Reviews Meta’s $2 Billion AI Deal With Manus Amid Technology Control Concerns
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations
Hyundai Motor Shares Surge on Nvidia Partnership Speculation
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid
FDA Limits Regulation of Wearable Devices and Wellness Software, Boosting Health Tech Industry
Barclays Invests in Stablecoin Clearing Firm Ubyx to Advance Digital Money Strategy
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
Lenovo Unveils AI Cloud Gigafactory With NVIDIA and Launches New AI Platform at CES 2026
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Newmont Goldcorp Expects Lower Q1 2026 Gold Output After Western Australia Bushfire
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
Chevron Seeks Expanded U.S. License to Boost Venezuelan Oil Exports Amid Sanctions Talks
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
AMD Unveils Next-Generation AI and PC Chips at CES, Highlights Major OpenAI Partnership
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 



